Fig. 3 | Scientific Reports

Fig. 3

From: MYH9 promotes malignant progression of glioma cells through regulating β-catenin stability via epithelial-mesenchymal transition signaling pathway

Fig. 3

The upregulation of MYH9 correlated with poor prognosis in gliomas. (A,B) Survival analysis from CGGA database suggested that mRNA expression level of MYH9 had a negaitive relationship with glioma patients’ survival time. (C,D) The results of UALCAN database suggested that patients with low expression of MYH9 had a longer survival time compared to patients with high expression. Data are presented as the mean ± SD for three independent experiments.

Back to article page